Long-term survival and death causes of systemic lupus erythematosus in China: A systemic review of observational studies

Medicine (United States)

Volumn 94, Issue 17, 2015, Pages e794-

  Wang, Ziqian ^a   Wang, Yanhong ^b   Zhu, Rongrong ^a   Tian, Xinping ^a   Xu, Dong ^a   Wang, Qian ^a   Wu, Chanyuan ^a   Zhang, Shangzhu ^a   Zhao, Jiuliang ^a   Zhao, Yan ^a   Li, Mengtao ^a   Zeng, Xiaofeng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN DISEASE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHINA; CHINESE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFECTION; KIDNEY DISEASE; LIVER DISEASE; LONG TERM SURVIVAL; LUNG DISEASE; MULTIPLE ORGAN FAILURE; NEOPLASM; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; EPIDEMIOLOGY; MORTALITY; RISK FACTOR; SURVIVAL;

CHINA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84937512156     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000794     Document Type: Article

References (87)

1. Doria A, Gatto M, Zen M, et al. Optimizing outcome in SLE: treating-to-target and definition of treatment goals. Autoimmun Rev. 2014;13:770-777.
2. Mak A, Cheung MWL, Chiew HJ, et al. Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s. Semin Arthritis Rheum. 2012;41:830-839.
3. Yurkovich M, Vostretsova K, Chen W, et al. Overall and causespecific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res. 2014;66:608-616.
4. Ferucci ED, Johnston JM, Gaddy JR, et al. Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people, 2007-2009. Arthritis Rheumatol. 2014;66:2494-2502.
5. Lim SS, Bayakly AR, Helmick CG, et al. The Incidence and Prevalence of Systemic Lupus Erythematosus, 2002-2004: the Georgia Lupus Registry. Arthritis Rheumatol. 2014;66:357-368.
6. See L, Kuo C, Chou I, et al. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum. 2013;43:381-386.
7. Jakes RW, Bae S, Louthrenoo W, et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res. 2012;64:159-168.
8. Flower C, Hennis AJM, Hambleton IR, et al. Systemic lupus erythematosus in an Afro-Caribbean population: incidence, clinical manifestations and survival in the Barbados national lupus registry. Arthritis Care Res. 2012;64:1151-1158.
9. Pons-Estel GJ, Alarcón GS, Scofield L, et al. Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus. Semin Arthritis Rheum. 2010;39:257-268.
10. Mok CC, To CH, Hod LY, et al. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J Rheumatol. 2008;35:1978-1982.
11. Mok C. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus. 2011;20:767-771.
12. Golder V, Connelly K, Staples M, et al. Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic. Lupus. 2013;22:1425-1430.
13. Jakes RW, Bae S, Louthrenoo W, et al. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res. 2012;64:159-168.
14. Connelly K, Morand EF, Hoi AY. Asian ethnicity in systemic lupus erythematosus: an Australian perspective. Intern Med J. 2013;43:618-624.
15. Ong C, Nicholls K, Becker G. Ethnicity and lupus nephritis: an Australian single centre study. Intern Med J. 2011;41:270-278.
16. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1993;72:113-124.
17. Mok CC. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus. 2011;20:767-771.
18. Yeh KW, Yu CH, Chan PC, et al. Burden of systemic lupus erythematosus in Taiwan: a population-based survey. Rheumatol Int. 2013;33:1805-1811.
19. Takkouche B, Etminan M, Montes-Martinez A. Personal use of hair dyes and risk of cancer: a meta-analysis. JAMA. 2005;293:2516-2525.
20. Bhutta AT, Cleves MA, Casey PH, et al. Cognitive and behavioral outcomes of school-aged children who were born preterm: a metaanalysis. JAMA. 2002;288:728-737.
21. Wu G, Jia X, Gao D, et al. Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center. Clinical Rheumatol. 2014;33:947-953.
22. Feng X, Zou Y, Pan W, et al. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus. Lupus. 2014;23:327-334.
23. Mok CC, Chan PT, Ho LY, et al. Prevalence of the antiphospholipid syndrome and its effect on survival in 679 Chinese patients with systemic lupus erythematosus: a cohort study. Medicine (United States). 2013;92:217-222.
24. Wei H, Hong X, Mei C. Survival rates and associated risk factors for systemic lupus erythematosus in Yunnan province (Chinese). Paper presented at: the 15th National Conference on Dermatovenereology of Chinese Medical Association; 2009; Tianjin, China.
25. Sheng C, Shunle C. An eighteen-year follow-up study of systemic lupus erythematosus (Chinese). Chinese J Rheumatol. 2000;4:27-31.
26. Yingying Z, Jiansheng W, Zhonghe L. Analysis on cause death of 50 patients with systemic lupus erythematosus (Chinese). Central Plains Med J. 2000;27:18-19.
27. Yong C. Death cause analysis of systemic lupus erythematosus (Chinese). Ningbo Medical. 1998;10:172.
28. Ciguang M, Daoyou Z, Rengao Y. Analysis of causes of death in 90 patients with systemic lupus erythematosus (Chinese). Chinese J Nephrol. 1998;14:114-116.
29. Ruijun L, Kuo W, Zhong L. Analysis of the death cause on 42 dead cases with systemic lupus erythemalosus (Chinese). J Dali Med Coll. 2000;9:11-12.
30. Zhongyi C. Analysis of death causes on 48 dead cases with systemic lupus erythematosus (Chinese). Fujian Med J. 2006;28:55-57.
31. Linjie C, Zhijun L, Weidong C, et al. Cause of death analysis of 25 cases with systemic lupus erythematosus (Chinese). J Bengbu Med Coll. 1997;22:97.
32. Danhong Y, Rengao Y. Death cause analysis of 50 systemic lupus erythematosus patients (Chinese). J Postgrad Med. 1998;21:249-250.
33. Shangbei S. Analysis of causes in 64 death cases with systemic lupus erythematosus (Chinese). Chin J Derm Venereol. 1997;11:27-28.
34. Zhiling C, Xingqi Z. Analysis of the causes of death in 67 systemic lupus erythematosus patients (Chinese). J Clin Dermatol. 1996(02).
35. Shufan L, Lijuan Z. Death cause analysis on patients with systemic lupus erythematosus (Chinese). Liaoning Med J. 1996(03).
36. Xueyi J, Xiazhe F, Xueli Y. Clinical study of 1000 cases with systemic lupus erythematosus (Chinese). Chinese J Dermatovenerol. 1993(02):76-79.
37. Huanqin C, Tiezheng T, Fengshan Z. Analysis of death cases with systemic lupus erythematosus (Chinese). J Harbin Med Univ. 1995(03).
38. Zhongying W, Feng L, Ping Z. Analysis of common causes in patients with systemic lupus erythematosus (Chinese). Jilin Med J. 1991(05).
39. Xiangpei L, Xiaomei L. Cause of death analysis on 35 systemic lupus erythematosus patients (Chinese). Anhui Med J. 1994(02).
40. Qin W, Qian W, Xiaofeng Z. Analysis of death causes in 187 patients with systemic lupus erythematosus (Chinese). China Med. 2008;3:598-599.
41. Shouyi S. Death cause analysis of 110 cases in systemic lupus erythematosus (Chinese). Chinese J Dermatol. 1984;3:153-156.
42. Fei Y, Shi X, Gan F, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clinical Rheumatol. 2014;33:57-63.
43. Liya Y, Bang A, Huijie L. Death cause analysis of 88 systemic lupus erythematosus patients (Chinese). Henan Med Info. 2002;10:20-21.
44. Tao S, Weiguo X. Cause of death analysis on 33 cases of systemic lupus erythematosus (Chinese). J China Med Univ. 2014;43:850-851.
45. Weiwei C, Xiao S. Analysis of the death causes in 26 systemic lupus erythematosus patients (Chinese). J Clin Intern Med. 2012;29:494.
46. Jin-xiong H, Min W, Le W, et al. The cause of death analysis in patient with systemic lupus erythematosus (an analysis of 25 cases) (Chinese). Clin Misdiag Misther. 2012;25:92-94.
47. Fengjiao G, Wencheng Q. Analysis on the death-associated factors in 25 systemic lupus erythematosus patients (Chinese). New Med. 2012;43:38-41.
48. Jinmei Z, Jing Y, Yi L. Infection of patients died from systemic lupus erythematosus (Chinese). Med J West China. 2011;23:356-358360.
49. Jiafeng S, Xiangpei L, Jinhui T. Analysis of death causes in 47 patients with systemic lupus erythematosus (Chinese). Anhui Med J. 2010;31:768-770.
50. Xuejun H, Qinglian O, Xueqiong L, et al. Analysis of the causes of death and associated factor of 31 systemic lupus erythematosus patients (Chinese). China Clin Prac Med. 2010;04:63-64.
51. Danqi D, Hong X, Haiqiong Y. Cause of death analysis in 43 systemic lupus erythematosus patients (Chinese). Chinese J Rheumatol. 2008;12:285.
52. Lin P. Causes and Risk Factors Associated with Death of 64 Patients With Systemic Lupus Erythematosus: A Retrospective Case-Control Study (Chinese) [master's thesis]. Department of Dermatology and Venereology, Fudan University; 2007..
53. Guan-ling Z, Qiu-sheng Z. Clinic analysis of death causes in 56 patients with systemic lupus erythematosus (Chinese). Appl J Gen Pract. 2007;5:604-605.
54. Ling L, Xiangui C. Analysis of death causes in 36 patients with systemic lupus erythematosus (Chinese). Paper presented at: the Fourth Annual Conference of Dermatovenereology in Western China; 2006, Urumchi, China.
55. Li-min R, Hua YE, Jin-xia Z, et al. Analysis of 5-year survival rate and prognostic indicators of systemic lupus erythematosus (Chinese). Chinese J Rheumatol. 2009;13:156-158.
56. Weifang Z. Analysis of the Survival Rate and Related Factors in Hospitalized Systemic Lupus Erythematosus Patients (Chinese) [master's thesis]. Department of Dermatology and Venereology, Zhejiang University; 2006.
57. Yijin L, Fanqin Z, Guozhen T, et al. Analysis on the causes of death in 131 systemic lupus erythematosus patients (Chinese). Guangdong Med. 2004;25:689-690.
58. Wen-Hui H, Yi T, Na YU. A 10-year analysis of the causes of death and associated factors in systemic lupus erythematosus (Chinese). Acad J Guangzhou Med Coll. 2004;32:42-44.
59. Zhanquan H, Xiaodong W, Ji C. Death cause analysis in patients with systemic lupus erythematosus (Chinese). Bull Med Res. 2003;32:41-42.
60. Voss A, Laustrup H, Hjelmborg J, et al. Survival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish community. Lupus. 2013;22:1185-1191.
61. Kuan WP, Li EK, Tam LS. Lupus organ damage: what is damaged in Asian patients? Lupus. 2010;19:1436-1441.
62. Thomas G, Mancini J, Jourde-Chiche N, et al. Mortality associated with systemic lupus erythematosus in France assessed by multiplecause- of-death analysis. Arthritis Rheumatol. 2014;66:2503-2511.
63. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2550-2557.
64. Xu G, Liu M, Yu K. A prospective study of nosocomial infection in patients with systemic lupus erythematosus. Chin J Rheumatol. 2003;7:216-219.
65. Danza A, Ruiz-Irastorza G. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus. 2013;22:1286-1294.
66. Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35:2950-2959.
67. National Center for Cardiovascular Disease. Report on Cardiovascular Diseases in China (2013). China: Encyclopedia of China Publishing House; 2013.
68. de Fatima Marinho De Souza M, Gawryszewski VP, Ordunez P, et al. Cardiovascular disease mortality in the Americas: current trends and disparities. Heart. 2012;98:1207-1212.
69. Gustafsson JT, Svenungsson E. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. Autoimmunity. 2014;47:67-76.
70. Magder LS, Petri M. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol. 2012;176:708-719.
71. Cairoli E, Rebella M, Danese N, et al. Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect. Lupus. 2012;21:1178-1182.
72. Jung H, Bobba R, Su J, et al. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthritis Rheum. 2010;62:863-868.
73. Borowoy AM, Pope JE, Silverman E, et al. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum. 2012;42:179-185.
74. Hanly JG, Urowitz MB, Su L, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2010;69:529-535.
75. Zhou H, Zhang F, Tian X, et al. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients. Lupus. 2008;17:93-99.
76. Li M, Zhang W, Leng X, et al. Chinese SLE treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus. Lupus. 2013;22:1192-1199.
77. Hanly JG, McCurdy G, Fougere L, et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol. 2004;31:2156-2162.
78. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol. 2003;30:985-992.
79. Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2001;28:766-771.
80. Kasitanon N, Louthrenoo W, Piyasirisilp S, et al. Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol. 2002;20:179-185.
81. Keane MP, Lynch JR. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax. 2000;55:159-166.
82. Shen M, Wang Y, Xu WB, et al. Pleuropulmonary manifestations of systemic lupus erythematosus (Chinese). Chinese Medical Journal. 2005;85:3392-3395.
83. Li M, Wang Q, Zhao J, et al. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus. 2014;23:1085-1091.
84. Hao YJ, Jiang X, Zhou W, et al. Connective tissue diseaseassociated pulmonary arterial hypertension in Chinese patients. Eur Respir J. 2014;44:963-972.
85. Cheema GS, Quismorio FJ. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med. 2000;6:424-429.
86. Shen M, Zeng X, Tian X, et al. Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China. Lupus. 2010;19:1326-1330.
87. Kwok SK, Moon SJ, Ju J, et al. Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea. Lupus. 2011;20:102-107.